Treatment of rheumatoid arthritis: we are getting there
- PMID: 19560809
- DOI: 10.1016/S0140-6736(09)60792-3
Treatment of rheumatoid arthritis: we are getting there
Comment on
-
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.Lancet. 2009 Jul 18;374(9685):210-21. doi: 10.1016/S0140-6736(09)60506-7. Epub 2009 Jun 26. Lancet. 2009. PMID: 19560810 Clinical Trial.
Similar articles
-
New drugs for rheumatoid arthritis.N Engl J Med. 2004 Aug 26;351(9):937-8. doi: 10.1056/NEJM200408263510922. N Engl J Med. 2004. PMID: 15329436 No abstract available.
-
Disease-modifying antirheumatic drugs: enhancing efficacy by combination.Lancet. 2004 Feb 28;363(9410):670-1. doi: 10.1016/S0140-6736(04)15660-2. Lancet. 2004. PMID: 15001319 No abstract available.
-
Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?J Rheumatol. 2006 Feb;33(2):433; author reply 433-4. J Rheumatol. 2006. PMID: 16465676 No abstract available.
-
Adalimumab for rheumatoid arthritis?Am Fam Physician. 2006 Feb 1;73(3):435-6. Am Fam Physician. 2006. PMID: 16479667 Review. No abstract available.
-
[Biologic therapy with anti-TNFα in rheumathoid arthritis].Reumatismo. 2005;57(4 Suppl):17-21. Reumatismo. 2005. PMID: 16385351 Review. Italian.
Cited by
-
Efficacy, safety and tolerability of tofacitinib in patients with an inadequate response to disease modifying anti-rheumatic drugs: a meta-analysis of randomized double-blind controlled studies.BMC Musculoskelet Disord. 2013 Nov 26;14:332. doi: 10.1186/1471-2474-14-332. BMC Musculoskelet Disord. 2013. PMID: 24279308 Free PMC article.
-
Impact of Rheumatoid Arthritis on Alopecia: A Nationwide Population-Based Cohort Study in Taiwan.Front Med (Lausanne). 2020 Apr 28;7:150. doi: 10.3389/fmed.2020.00150. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32411714 Free PMC article.
-
Golimumab for rheumatoid arthritis.Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD008341. doi: 10.1002/14651858.CD008341. Cochrane Database Syst Rev. 2010. PMID: 20091667 Free PMC article.
-
Tofacitinib, an oral Janus kinase inhibitor, in patients from Brazil with rheumatoid arthritis: Pooled efficacy and safety analyses.Medicine (Baltimore). 2018 Aug;97(31):e11609. doi: 10.1097/MD.0000000000011609. Medicine (Baltimore). 2018. PMID: 30075534 Free PMC article. Clinical Trial.
-
Can Disease-Modifying Anti-Rheumatic Drugs Reduce the Risk of Developing Dementia in Patients with Rheumatoid Arthritis?Neurotherapeutics. 2019 Jul;16(3):703-709. doi: 10.1007/s13311-019-00715-6. Neurotherapeutics. 2019. PMID: 30945124 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical